
Why A Shark's Pancreas Could Rewrite Immunology
When we think of the pancreas, we think digestion, not defense. But in the nurse shark, that assumption has just been flipped on its head. New research reveals that this organ, tucked behind the stomach, doesn't just make enzymes and hormones — it's also an unexpected site of sophisticated immune activity.
Until now, the spleen was thought to be the only secondary lymphoid organ (SLO) in cartilaginous fish like sharks, rays, and skates. SLOs are critical zones where immune cells meet up, exchange information, and coordinate defenses against pathogens. In mammals, we have the spleen, lymph nodes, and gut-associated lymphoid tissue. But sharks don't have lymph nodes, and their gut-associated tissues don't show the same level of organization. So how do they coordinate immune responses? This study suggests the answer lies in a distributed network of immune-active tissues including the pancreas.
This wasn't discovered easily. Researchers acquired juvenile nurse sharks (Ginglymostoma cirratum) from the coastal waters around Florida and housed them in controlled, artificial seawater tanks to ensure they were healthy and acclimated before any testing. Some of these sharks were then immunized, meaning they were exposed to foreign proteins like phycoerythrin (a fluorescent protein often used in lab studies) or the SARS-CoV-2 spike protein to simulate an infection. These antigens were delivered either under the skin or intravenously, sometimes multiple times over the course of weeks. A few sharks were left unimmunized to serve as healthy controls. After the immunization period, the sharks were humanely euthanized and their organs, including the pancreas and spleen, were collected for analysis. The scientists used a technique called RNAscope fluorescence in situ hybridization; this method allowed them to visualize the location of specific RNA molecules within tissue sections. This was also paired with immunofluorescence microscopy, which uses antibodies linked to fluorescent dyes to tag specific proteins or cells. Together, these tools let researchers map out which immune cells were where, what genes they were expressing, and whether they were actively responding to the immunization.
Juvenile nurse shark resting under a rock ledge. (Photo by Wild Horizons/Universal Images Group via ... More Getty Images)
Traditionally we think of the pancreas as playing two key roles: making enzymes that help digest food and producing hormones like insulin to regulate blood sugar. But in nurse sharks, researchers found that the pancreas contains structured clusters of immune cells called B cell follicles. These are not scattered randomly, but are well-organized and sit apart from the parts of the pancreas that handle digestion or hormone production. Even more striking is how these B cell follicles behave. They mirror what's found in the spleen, which has long been recognized as a major player in immune defense. Like in the spleen, these pancreatic follicles hold onto intact pieces of pathogens (called antigens) and use them to help select the right B cells to fight off infection. After being exposed to a new antigen, such as during an experimental immunization, the nurse shark's pancreas actually began producing targeted antibodies, specific to that antigen.
These pancreatic B cell follicles weren't just found in immunized sharks. They were also present in healthy, unimmunized ones, showing that these structures aren't created by artificial stimulation. They are a normal part of nurse shark anatomy. This means the pancreas has been playing an immune role all along… we just hadn't looked closely enough. But it's not just B cells! The researchers also found clusters of T cells in the pancreas, including a population enriched in transcripts for TCR-γ, AID, and Ki67, suggesting active proliferation and somatic hypermutation. This is a process usually associated with fine-tuning immune cell receptors to better recognize pathogens. What's particularly curious is that these T cells likely don't rely on the major histocompatibility complex (MHC) for antigen recognition, hinting that they might behave like mammalian γδ T cells. In mammals, these types of cells are known for rapid responses at mucosal surfaces, where they help protect against infections in places like the gut and lungs.
So why would the pancreas be involved in this? One theory is that it provides a shortcut. The antibodies generated there could be funneled directly into the spiral valve (a structure in the shark's intestine) through the pancreatic duct. This would offer quick, local protection in a microbe-rich environment, which is especially useful for an animal constantly exposed to seawater both externally and internally. Mammals, on the other hand, have compartmentalized immune responses depending on how pathogens enter the body (e.g. skin, gut, lungs, etc.). For sharks, this direct 'crosstalk' between peripheral and mucosal immunity might be an evolutionary adaptation to life in the ocean.
These findings showed that the shark pancreas wasn't just involved in digestion, but also functioned ... More as a secondary lymphoid organ, participating in immune surveillance and response. This challenges long-held assumptions that only the spleen played that role in sharks, and opens the door to rethinking how immune systems are structured in other vertebrates (especially those without mammal-like lymph nodes).
This new discovery, the authors highlight, challenges a long-standing view that the spleen is the only organ in sharks capable of organizing and initiating adaptive immune responses. Other organs like the liver, brain, gills, and even the olfactory system have shown signs of immune activity in past studies. But whether they act as full-fledged SLOs hasn't been confirmed. Now that we know the pancreas does, it opens the door to looking more carefully at other tissues. And these implications go beyond sharks. The same tools used here could help uncover hidden immune structures in birds, reptiles, amphibians, and even humans! If the pancreas can act as an immune command center in a jawed vertebrate that split from our lineage over 400 million years ago, what other secrets are we missing about immune system evolution? The absence of lymph nodes in these ancient species might suggest that evolution found… other ways… to build efficient immune surveillance networks.
The nurse shark has offered us a glimpse into a system that works without the blueprint we've come to expect. Understanding these alternative immune strategies might help us design better therapies or vaccines by revealing overlooked immune pathways in our own bodies. For now, the nurse shark's pancreas reminds us that sometimes, looking at things differently — both literally and scientifically — can shift the entire narrative.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
SpaceX delays launch of NASA TRACERS mission until Wednesday
July 22 (UPI) -- The NASA TRACERS mission is set to launch on Wednesday atop a SpaceX Falcon 9 rocket after SpaceX postponed Tuesday's launch due to "airspace concerns." SpaceX officials scrubbed Tuesday's launch at Vandenberg Space Force Base in California just 45 seconds before liftoff. The launch was canceled "due to [Federal Aviation Administration] airspace concerns that created a no-go condition for launch," SpaceX posted on social media. Wednesday's launch is scheduled for 11:13 a.m. PDT with a 57-minute launch window to send NASA's twin Tandem Reconnection and Cusp Electrodynamics Reconnaissance Satellites into orbit. The TRACERS mission aims to "help understand magnetic reconnection and its effects in Earth's atmosphere." NASA will also send three payloads, the Athena EPIC, the Polylingual Experimental Terminal and the Relativistic Electron Atmospheric Loss, with the mission. The mission's launch window opens at 11:13 a.m. PDT on Wednesday with a 57-minute window from the Vandenberg Space Force Base's Space Launch Complex 4 East. About eight minutes after liftoff, Falcon 9's first stage will land on SpaceX's Landing Zone 4 at Vandenberg Space Force Base, according to SpaceX. "There is the possibility that residents of Santa Barbara, San Luis Obispo, and Ventura counties may hear one or more sonic booms during the landing, but what residents experience will depend on weather and other conditions," SpaceX officials said.
Yahoo
17 minutes ago
- Yahoo
Popular Ice Cream Brand Recalled Across 23 States for This Dangerous Reason—Here's What to Know
Popular Ice Cream Brand Recalled Across 23 States for This Dangerous Reason—Here's What to Know originally appeared on Parade. There's nothing better than a sweet treat like ice cream on a hot summer day. It's cool and refreshing, sweet and creamy, and all around everything right in the world. You can enjoy it in your favorite flavors, whether you prefer more classic fare like cookies and cream or something a bit more out there like mustard or blueberry goat cheese with basil pesto swirl. Ice cream is quintessential summer, and despite the fact that we enjoy it year-round, it tastes so much better in the sunshine. 😋😋SIGN UP to get delicious recipes, handy kitchen hacks & more in our daily Pop Kitchen newsletter🍳🍔 As sweet and unassuming as ice cream can be, though, sometimes it isn't the safe, innocuous treat that we've come to know and love. Beyond the fact that it can be a sugar and cholesterol bomb, if it isn't made right, it can actually be dangerous. Ice cream can be a breeding ground for bacteria due to fluctuations in temperature during processing and improper cleaning of equipment, and you might not know until it's too late. Luckily, there are safeguards in place to catch any potential issues before our favorite summer treat makes it to our freezers—but that doesn't mean that accidents don't you might want to double-check your freezer to make sure you don't have one of the slew of items affected by a recent recall affecting ice cream bars sold in a whopping 23 states. According to recent filings by the FDA, over 100,000 ice cream bars produced by Rich's Ice Cream were recalled due to concerns over potential listeria contamination. The recall, which impacts lot number 24351 through lot 25156, was initiated on June 27, according to the FDA notice, and is classified as Class II with a total of 110,292 cases potentially affected. The impacted products include Chocolate Crunch Cake Bars, Strawberry Shortcake Bars, Rich Bars, Crumbled Cookie Bars, Orange Cream Bars, Fudge Frenzy Bars, Cotton Candy Twirl Bars, Savagely Sour Blue Raspberry Bars, Savagely Sour Cherry Bars, and Cool Watermelon Bars. Additionally, the frozen treats were individually packaged in plastic bags and sold in master cases. As if the list of items weren't exhaustive enough, the potentially contaminated products were sold in Alabama, Arizona, California, South Carolina, Florida, Georgia, Illinois, Iowa, Louisiana, Massachusetts, Missouri, Nebraska, Nevada, New Jersey, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Virginia, and Wisconsin. They were also distributed and sold in Nassau, Bahamas. Talk about ruining your summer vacation. So far, there don't appear to be any reported illnesses, but it's worth it to tread with caution if you think you might have purchased the affected products. To find out more information or contact Rich's Ice Cream Co., you can visit their website, and be sure to check back here for the latest food Ice Cream Brand Recalled Across 23 States for This Dangerous Reason—Here's What to Know first appeared on Parade on Jul 22, 2025 This story was originally reported by Parade on Jul 22, 2025, where it first appeared. Solve the daily Crossword
Yahoo
31 minutes ago
- Yahoo
Man's Deadly Brain Tumor Vanishes After Taking Breakthrough Drug: ‘Lucky Break in a Devastating Situation'
A man with one of the deadliest forms of brain cancer is now hopeful for the future after his tumor completely disappeared thanks to a breakthrough drug. In October 2022, Ben Trotman was 40 years old when he was diagnosed with glioblastoma, a rare form of terminal cancer that kills more than 10,000 Americans a year, according to the National Brain Tumor Society. Glioblastoma, also known as GBM, has no known cure. Standard treatment involves surgery to remove the tumor (if possible), followed by radiation and chemotherapy. The disease is considered a highly invasive tumor in the central nervous system because its cells reproduce extremely quickly. Those who are diagnosed with the malignant tumor have a median survival rate of about 14 to 14.5 months. Following his diagnosis, Trotman was referred by a friend to The National Hospital for Neurology and Neurosurgery at University College London Hospitals (UCLH). There, Dr. Paul Mulholland, a consultant medical oncologist, recruited Trotman to be the first patient in his clinical trial. The trial involved him receiving the immunotherapy drug ipilimumab to treat his glioblastoma before undergoing any standard treatment. Afterward, Trotman began radiation and chemotherapy. 'The crucial element of this trial is that patients will have their immune system boosted by the drug before they have any other treatment, when they are fit and well enough to tolerate the immunotherapy,' Mulholland said in a press release. The PEOPLE Puzzler crossword is here! How quickly can you solve it? Play now! Two years and eight months after being the sole participant in the clinical trial, Trotman, now 43, is tumor-free, and his scans have come back clear. 'It is very unusual to have a clear scan with glioblastoma, especially when he didn't have the follow-up surgery that had been planned to remove all of the tumour that was initially visible on scans,' Mulholland explained. 'We hope that the immunotherapy and follow-up treatment Ben has had will hold his tumour at bay, and it has so far, which we are delighted to see.' Mulholland added that his goal is to find a cure for the 'devastating disease' that is glioblastoma, and he's hoping to move forward with additional patients. Trotman is now married to wife Emily, and the couple welcomed daughter Mabel in April. The couple told the hospital that the clinical trial gave Trotman his life back. 'Getting this diagnosis was the most traumatic experience,' Emily said. 'We were grappling with the fact that Ben had gone from being apparently perfectly healthy to having months to live. Had we not met Dr. Mulholland, that would have been it for us. We felt we had a lucky break in an otherwise devastating situation.' 'We obviously don't know what the future holds, but having had the immunotherapy treatment and getting these encouraging scan results has given Emily and I a bit of hope,' Trotman added. 'We are focused on rebuilding the life we thought we had lost and enjoying being parents.' The new father said he's hoping that his brain cancer journey will give others hope and inspire more patients to participate in the next clinical trial. Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. is now available in the Apple App Store! Download it now for the most binge-worthy celeb content, exclusive video clips, astrology updates and more! Dame Siobhain McDonagh — member of parliament of the UK who lost her sister from glioblastoma in 2023 — led a fundraising campaign and raised more than €1 million to cover the costs of the next trial. 'My beloved sister Margaret was appalled to discover that there had been no advances in brain cancer treatment for decades when she was diagnosed with glioblastoma,' McDonagh said. 'Changing this was Margaret's final campaign and one that I have continued in her memory. I am so grateful to the many people who knew and respected Margaret who have come together and helped to raise funds and campaign for this new trial that we are calling Margaret's Trial.' Mullholland recalled meeting Margaret. 'When I met Margaret, she said to me, 'What can I do to support you to cure this disease?'" 'I am incredibly grateful to her and to Siobhain, whose campaigning and fundraising in her sister's memory has led to this new clinical trial opening for patients with this most aggressive form of brain cancer that has such a poor prognosis.' Read the original article on People